Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-05

Clinical Trial Update: PET Imaging of Brain Amyloid in Normal Pressure Hydrocephalus [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating PET imaging of brain amyloid in normal pressure hydrocephalus has been completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PET imaging tracer (unspecified)

Snippet

Sponsor: GE Healthcare | Conditions: Normal Pressure Hydrocephalus | Phase 3 | Status: COMPLETED | Results posted: 2012-06-05